COBRE brochure FINAL:Layout 1
…Cancer Therapeutics Symposium Rhode Island Hospital offers "superior cancer surgeons, radiation oncologists and interventional radiology." - HOWARD SAFRAN, MD death in southeastern New England. At present, the CCRD supports the cancer research efforts of 15 cancer investigators and provides them with… related searches:liver cancer | dupuy
Progress
…recommended three applications for funding. Awards of $25,000 were made to the following teams of investigators: * Maureen Chung, MD, PhD and Howard Safran, MD, to explore the efficacy of a BCG-based MUC1 vaccine for inhibiting pancreatic cancer in a transgenic mouse model of spontaneous pancreatic cancer… related searches:peter quesenberry
2003 - 2004
…Taking this into consideration, awards of $25,000 were made to the following teams of investigators: * Maureen Chung, MD, PhD, a surgeon, and Howard Safran, MD, an oncologist, to explore the efficacy of a BCG-based MUC1 vaccine for inhibiting pancreatic cancer in a transgenic mouse model of spontaneous… related searches:peter quesenberry | stem cell
"I could not have been treated better."
…sometimes even humorous. I think that is what gets you through this dreaded illness most of the time is that ability to see the funny side of life. Dr. Safran and Dr. DiPetrillo are the best. They are very caring and thorough in the care of their patients. They never gave me false hope, were honest in their… related searches:dipetrillo
Judy Michalenka
…necessary to get better. Initially she was referred to her surgeon, who wanted her to first see an oncologist and referred her to Howard P. Safran, MD. Safran made time to see her that week. "Suddenly someone says to you, 'you have cancer, and it is very serious cancer.' You don’t know where to turn…
2009 July
…more effective treatment for this cancer, the fourth leading cause of cancer deaths in the country, is imperative. Under the direction of Howard Safran, MD, a specialist in pancreatic cancer, Lifespan’s oncology clinical research department will recruit patients from both Rhode Island Hospital and…
2009 July
…more effective treatment for this cancer, the fourth leading cause of cancer deaths in the country, is imperative. Under the direction of Howard Safran, MD, a specialist in pancreatic cancer, Lifespan’s oncology clinical research department will recruit patients from both Rhode Island Hospital and…
